FDA launches Neuroscience Advancement and Innovation Nexus program

SHOTS Desk · Fri · 23 Oct 2026 · 20:35 · Reported

The FDA has launched the Neuroscience Advancement and Innovation Nexus, or NAIN, a new agency program aimed at accelerating medical product development in neuroscience. The agency says the program is aligned with the Trump Administration's efforts to advance medical innovation and deliver breakthrough treatments.

Read it at U.S. Food and Drug AdministrationSHOTS Desk
FDA launches Neuroscience Advancement and Innovation Nexus program · SHOTS